Cardiovascular Disease Doctors in Fort Belvoir, VA Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Dr. Rebecca Margaret Seifried, D.O. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-2008

Mukul Bhatnagar, Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 571-231-2160

Michael Sean Scully, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9300 Dewitt Loop, Fort Belvoir, VA 22060 Phone: 703-231-2008

Dr. Daniel George Gates, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 9300 Dewitt Loop, Fort Belvoir Community Hospital, Fort Belvoir, VA 22060 Phone: 571-231-9075    Fax: 571-231-2115

News Archive

Closure of women's health clinics linked to lower cervical cancer screening and higher mortality

Following the closure of nearly 100 women's health clinics across the United States from 2010 to 2013, fewer women were screened for cervical cancer, more women were diagnosed with advanced stages of the disease and mortality rates rose.

Physicians, researchers to discuss advances in cancer immunotherapies at UChicago symposium

The Ben May Department for Cancer Research at the University of Chicago will hold a day-long symposium on cancer immunotherapy for physicians and researchers.

Study discovers mechanism by which bioscaffolds influence cellular behavior

A study from the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine identifies a mechanism by which bioscaffolds used in regenerative medicine influence cellular behavior, a question that has remained unanswered since the technology was first developed several decades ago.

Thomson Reuters' report on path to eliminate $3.6 trillion in wasteful healthcare spending

A report issued by Thomson Reuters and shared in part at the Aspen Ideas Festival on July 10th, indicates that a combination of better coordinated public and private sector care; stronger patient awareness of health risks and wellness; and application of improved information systems to eliminate fraud and abuse could lead to a 50% reduction in wasteful spending in healthcare, saving 3.6 trillion dollars over the next decade.

Stapled Peptide oncology drug candidate exhibits robust efficacy in xenograft cancer models

Aileron Therapeutics, Inc. and its collaborator Roche today announced new results of a preclinical study of its Stapled Peptide oncology drug candidate ATSP-7041, which exhibited robust efficacy in MDM2 and MDMX xenograft cancer models.

Read more Medical News

› Verified 8 days ago